Patent · US Active

Combination therapy for the treatment of Alzheimer's disease

US7935348B2 · kind B2 · utility

4Cited by

1References

10Claims

0Family size

Assignee

Affiris Forschungs-und Entwicklungs GmbH · AT

Inventors

Frank Mattner · Wien, AT
Walter Schmidt · Wien, AT

Key dates

Filing date	Jul 6, 2005
Grant date	May 3, 2011
Priority date	—
Expiry date	Feb 16, 2028

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61M1/3679
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to a method for treating Alzheimer's disease by inducing sequestration of amyloid β into a plasma with a Aβ-mimotope peptide, and treatment with an apheresis device such that a fixed carrier can come into contact with the blood or plasma flow and includes a receptor that binds to an amyloid-β precursor-protein (APP), the APP being removed from the blood with the apheresis device.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.